EcoDrugPlus

Beta-Secretase 1

Ensembl ID : ENSDARG00000101716
Gene Symbol: BACE1
5 Cross references
221 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSDARG00000020744
Gene Symbol: BDKRB1
8 Enzyme and pathways 5 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSDARG00000043664
Gene Symbol: BDKRB2
8 Enzyme and pathways 5 Cross references
160 Possible Orthologues:

C-Abl Oncogene 1, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSDARG00000035187
Gene Symbol: ABL1
30 Enzyme and pathways 5 Cross references
202 Possible Orthologues:

C-Ros Oncogene 1 , Receptor Tyrosine Kinase

Ensembl ID : ENSDARG00000087197
Gene Symbol: ROS1
4 Cross references
125 Possible Orthologues:

Calcitonin Receptor-Like B

Ensembl ID : ENSDARG00000011571
Gene Symbol: CALCRLB
5 Cross references
149 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSDARG00000008398
Gene Symbol: CACNA1C
7 Enzyme and pathways 5 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSDARG00000102773
Gene Symbol: CACNA1DA
7 Enzyme and pathways 5 Cross references
213 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, B

Ensembl ID : ENSDARG00000110642
Gene Symbol: CACNA1DB
3 Cross references
209 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, B

Ensembl ID : ENSDARG00000115603
Gene Symbol: CACNA1DB
3 Cross references
209 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1f Subunit

Ensembl ID : ENSDARG00000023683
Gene Symbol: CACNA1FB
4 Enzyme and pathways 5 Cross references
177 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1s Subunit, A

Ensembl ID : ENSDARG00000029457
Gene Symbol: CACNA1SA
4 Enzyme and pathways 5 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).